Jim Cramer recommends buying TG Therapeutics (TGTX) stock for its leadership and potential

  1. Jim Cramer recommended buying TG Therapeutics, Inc. (TGTX) stock, praising the company’s leadership and potential.
  2. TG Therapeutics, Inc. (TGTX) focuses on developing therapies for B-cell mediated diseases, including multiple sclerosis. ClearBridge Investments added TGTX to its investment portfolio in Q4 2024.
  3. ClearBridge Investments sees potential in TG Therapeutics, Inc. (TGTX) but believes other AI stocks offer better upside with less risk.
  4. Explore more stock insights with articles on the Best and Worst Dow Stocks and 10 Unstoppable Stocks. No disclosures mentioned in the article.

Read more at Yahoo Finance: “You Should Buy the Stock”